Elliott and Mediapro Discussed Italian Soccer-Rights Deal (Bloomberg) Paul Singer’s Elliott Management Corp. and Mediapro have discussed the possibility...
Keep Reading →
May 22 - Hedge Funds, Insider Trading - Comments
Eddie Lampert is Seeking to Sell Sears Assets to his Hedge Fund – This will be Bad for Sears (Verdict.co.uk) In wanting to sell Sears’ assets...
Keep Reading →
May 4 - Hedge Funds, Insider Trading - Comments
Struggling Hedge Fund Folger Hill is Merging with Another Fund (Business Insider) Hedge fund Folger Hill Asset Management is merging with Schonfeld Strategic...
Keep Reading →
April 11 - Hedge Funds, Insider Trading - Comments
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) (The Motley Fool) What happened: Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) are losing ground...
Keep Reading →
March 7 - Market Movers, News - Comments
On September 14, 2016, the FDA’s Oncologic Drugs Advisory Committee met to evaluate and discuss a drug called apaziquone. Apaziquone is a development...
Keep Reading →
September 28 - News, Stock Analysis - Comments
When things go well in biotech, it can be a great ride. When things repeatedly go well, however, it can be easy to forget how quickly, and how frequently...
Keep Reading →
September 16 - News, Stock Analysis - Comments
Next month, an advisory panel will get together to discuss, and rule upon, Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)’s lead bladder cancer development...
Keep Reading →
August 23 - News, Stock Analysis - Comments
In two separate filings with the U.S. Securities and Exchange Commission, Armistice Capital, led by Steven Boyd, disclosed massively cutting its activist...
Keep Reading →
September 3 - Hedge Funds, News - Comments
Steven Boyd‘s Armistice Capital has further increased its activist stake in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) to 4.24 million shares...
Keep Reading →
June 4 - Hedge Funds, News - Comments
Millennium Management, Spectrum Pharmaceuticals: Israel Englander and his hedge fund company Millennium Management now hold over 3.2 million shares of...
Keep Reading →
October 21 - Hedge Funds, News - Comments
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a...
Keep Reading →
September 12 - Hedge Funds, News - Comments
Is it smart to be bullish on Dyax Corp. (NASDAQ:DYAX)? Now, according to many of your fellow readers, hedge funds are viewed as delayed, old investment...
Keep Reading →
September 6 - News - Comments
Editor’s Note: Annaly Capital Management, Inc. (NYSE:NLY), American Capital Agency Corp. (NASDAQ:AGNC), CYS Investments Inc (NYSE:CYS), ARMOUR...
Keep Reading →
September 5 - News - Comments
Now, according to many market players, hedge funds are viewed as bloated, outdated investment tools of a forgotten age. Although there are over 8,000...
Keep Reading →
September 3 - News - Comments
Is it smart to be bullish on Sequenom, Inc. (NASDAQ:SQNM)? If you were to ask many traders, hedge funds are seen as useless, outdated investment vehicles...
Keep Reading →
August 30 - News - Comments
Should investors bullish on QLT Inc. (USA) (NASDAQ:QLTI) consider the following data? In the financial world, there are many indicators shareholders...
Keep Reading →
August 30 - News - Comments
For the last several years, certain stocks have remained cheap as the overwhelming presence of short sellers have made it more difficult for shares to...
Keep Reading →
July 12 - News - Comments
For the last five years, Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) CEO Rajesh Shrotriya has always insisted that Spectrum Pharmaceuticals, Inc. (NASDAQ...
Keep Reading →
July 8 - News - Comments
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) got crushed with a downgrade from Credit Suisse that led to a 6.3% loss on Monday. The stock is now trading...
Keep Reading →
June 25 - News - Comments
How can you double your investment literally overnight? Buy stocks of the right biotech companies. However, you can also cut your investment by half overnight...
Keep Reading →
June 13 - News - Comments
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) was in 12 hedge funds’ portfolio at the end of the first quarter of 2013. SPPI has experienced a decrease...
Keep Reading →
June 6 - News - Comments
Is Idenix Pharmaceuticals Inc (NASDAQ:IDIX) an excellent stock to buy now? Investors who are in the know are taking a bearish view. The number of bullish...
Keep Reading →
June 3 - News - Comments
QLT Inc. (USA) (NASDAQ:QLTI) has seen a decrease in enthusiasm from smart money recently. In today’s marketplace, there are tons of metrics shareholders...
Keep Reading →
June 3 - News - Comments
What’s the source of your investment strategy? Many look to great investors like Warren Buffett for guidance on how to invest. Some take what we...
Keep Reading →
May 13 - News - Comments
As I noted seven weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing...
Keep Reading →
April 17 - News - Comments
As I noted six weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing...
Keep Reading →
April 10 - News - Comments
Although the Nasdaq Composite is the only major U.S. index that’s nowhere near its all-time high, it still turned in an impressive gain of 8.2%...
Keep Reading →
April 7 - News - Comments
With the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) up 28% over the trailing-12-month period, it’s evident that investment dollars are willingly...
Keep Reading →
March 17 - News - Comments
Every investor would love to stumble upon the perfect stock. But will you ever really find a stock that provides everything you could possibly want? One...
Keep Reading →
March 14 - News - Comments
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a...
Keep Reading →
March 14 - Hedge Funds - Comments
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is hurting today after dialing back guidance for the year. Apparently the increased production by Sagent...
Keep Reading →
March 13 - News - Comments
After six straight record highs for the Dow Jones Industrial Average 2 Minute (Dow Jones Indices:.DJI), the market finally looks like it’s running...
Keep Reading →
March 13 - News - Comments
Yesterday, I published an article titled, “When Being Short Backfires!” So it’s only appropriate to look at the other side of the trade. Strangely...
Keep Reading →
March 13 - News - Comments
Just 10 days ago, I examined the bear thesis on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) as, amazingly, over half of its float was sold short. It...
Keep Reading →
March 13 - News - Comments
It Doesn’t Take Much to Reverse a Long-Term Shorted Stock Up until last week, Navistar International Corp (NYSE:NAV) traded with a one-year loss of...
Keep Reading →
March 12 - News - Comments
What’s the fastest growing drug in Celgene Corporation (NASDAQ:CELG)‘s portfolio? It isn’t Revlimid, Vidaza, or Abraxane. All three...
Keep Reading →
February 20 - News - Comments
Earnings season is now starting to wind down, with most companies already having reported their quarterly results. But there are still some companies...
Keep Reading →
February 19 - News - Comments
When seeking stocks for your portfolio, it makes sense to look for growing companies, and rapid growers understandably can be particularly enticing. Below...
Keep Reading →
February 6 - News - Comments
